PS
BIIB icon

Planned Solutions’s Biogen BIIB Stock Holding History

Planned Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200
Closed -$38.8K – 167
2024
Q3 		$38.8K Buy
+200
New +$41.8K 0.02% 330
2024
Q1 		– Sell
-200
Closed -$51.8K – 139
2023
Q4 		$51.8K Buy
+200
New +$49.1K 0.02% 281
2021
Q1 		– Sell
-200
Closed -$49K – 93
2020
Q4 		$49K Buy
+200
New +$51.6K 0.04% 198

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Planned Solutions's BIIB Position: Q4 2024 in Review

Planned Solutions sold out of Biogen (BIIB) in Q4 2024, closing a stake of 200 shares — an estimated $38.8K sold.

Planned Solutions first reported a position in BIIB in Q4 2020 and held it in 3 quarters. The position peaked at $51.8K in Q4 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Planned Solutions reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Planned Solutions sold 200 Biogen shares in Q4 2024, an estimated $38.8K.
  • Planned Solutions first reported a position in Biogen in Q4 2020 and held it in 3 quarters.
  • Planned Solutions's Biogen position peaked at $51.8K in Q4 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Planned Solutions's 13F filing for Q4 2024, filed 17 Jan 2025.